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Moderate wine consumption has shown the potential to delay the onset of neurode-
generative diseases. This study investigates the molecular mechanisms underlying the 
protective effects of wine-derived phenolic and aroma compounds in a neuroinflam-
mation model based on SIN-1 stress-induced injury in SH-SY5Y neuroblastoma cells. 
Cell pretreatment with microbial metabolites found in blood after wine consumption, 
3,4-dihydroxyphenylacetic (3,4-DHPA), 3-hydroxyphenylacetic acids and salicylic 
β-d-O-glucuronide, at physiologically concentrations (0.1–10 μM) resulted in increased 
cell viability versus SIN-1 control group (p <  0.05). Results also showed significant 
decreases in mitogen-activated protein kinase (MAPK) p38 and ERK1/2 activation as well 
as in downstream pro-apoptotic caspase-3 activity by some of the studied compounds. 
Moreover, pretreatment with p38, MEK, and ERK1/2-specific inhibitors, which have a 
phenolic-like structure, also resulted in an increase on cell survival and a reduction on 
caspase-3 activity levels. Overall, these results contribute with new evidences related to 
the neuroprotective actions of wine, pointing out that wine-derived human metabolites 
and aroma compounds may be effective at protecting neuroblastoma cells from nitrosa-
tive stress injury by inhibiting neuronal MAPK p38 and ERK1/2, as well as downstream 
caspase 3 activity.
Keywords: wine, polyphenols, gut phenolic metabolites, aroma compounds, mitogen-activated protein kinase, 
neuroprotection
Abbreviations: 3,4-DHPA, 3,4-dihydroxyphenylacetic acid; 4HPP, 3-(4-hydroxyphenyl) propionic acid; 3HPP, 3-(3-hydroxy-
phenyl) propionic acid; 3HPA, 3-hydroxyphenylacetic acid; SIN-1, 3-morpholinosydnonimine; MAPK, mitogen-activated 
protein kinases.
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inTrODUcTiOn
Oxidative and nitrosative stress play important roles in the 
development of neurodegenerative diseases such as Alzheimer’s 
and Parkinson’s (1). While the harmful effects of heavy alcohol 
intake are well-established (2), several epidemiological studies 
have suggested that low to moderate consumption of red wine 
(~250  mL per day) can be beneficial in delaying the onset of 
cognitive impairments in aging and neurodegenerative diseases 
(3–8). In agreement with this, evidence from human randomized 
controlled trials shows that acute supplementations with specific 
wine compounds, such as anthocyanins or flavonoids, report 
improvements in recognition and working memory, attention, and 
psychomotor function (5, 9). Moreover, in vivo studies in rodent 
models further support the idea that moderate red wine intake 
can impact cognitive function (10–12). In particular, replacement 
of water with a red wine (20% ethanol v/v) enriched in flavan-
3-ols (0.003–1.53  g/L) and anthocyanins (0.648  g/L), resulted 
in an improved cognitive performance when compared to 20% 
ethanol control group in rodents (10). Similarly, the intake of red 
wine during 7 months showed to be protective in an Alzheimer’s 
mice model, resulting in a reduction of cognitive deterioration 
and neuropathology, as measured by spatial memory tests and Aβ 
peptides clearance in Tg2576 mice (11, 12).
Red wine is a complex matrix rich in polyphenols, in particular 
flavan-3-ols, and also an important source of aroma compounds. 
Flavan-3-ols are metabolized in the human colon by microbial 
catabolism reactions (i.e., hydrolysis, oxidation), originating 
metabolites such as propionic acid, phenylacetic acid, and 
benzoic acids derivatives (13). Further metabolism in the liver 
results in an extensive conjugation into glucuronides, sulfates, 
and O-methyl derivatives. More importantly, these metabolites 
have been detected in human plasma at physiological micromolar 
concentrations following red wine intake (14). Several studies 
have further demonstrated an ability of gut-derived metabolites 
to cross the blood–brain barrier (BBB) both in in vitro and in vivo 
models (15–17), suggesting that these might be responsible of the 
described protective effects of red wine polyphenols in brain func-
tion and cognitive performance. On the other hand, wine aroma 
compounds, such as linalool and 1,8-cineole, have been exten-
sively described for their antioxidant, anti-inflammatory, and 
antimicrobial properties in in vitro models (18, 19). Interestingly, 
wine-derived aroma compounds are small lypophilic molecules, 
which have also been shown to cross the BBB and might equally 
contribute to beneficial effects in the central nervous system (20), 
although the underlying mechanism of action has not been fully 
characterized (21, 22).
Despite the increasing evidence of the potential of red-wine 
polyphenols to affect brain function, the underlying mechanisms 
by which these compounds might influence neuronal function 
remain to be established (23). Both, in vitro and in vivo studies 
suggest an ability of polyphenols, such as flavonoids, to interact 
with signaling pathways that modulate neuronal stress-induced 
apoptosis (24), including the nuclear factor-ĸB or mitogen-acti-
vated protein kinase (MAPK) pathways (in particular ERK1/2, 
JNK, and p38) (23, 24). These are known to activate downstream 
signals, such as STAT-1 (activator of transcription-1), related 
to pro-inflammatory responses in neurons (25, 26) as well as 
caspase-3 proteases activity, pro-apoptotic marker of cell death 
(27). While the interaction of flavonoids with such signaling 
pathways has been previously studied (1, 28), the effect of the 
physiological relevant human gut-derived metabolites (par-
ticularly phenolic acids) in neuronal function has been poorly 
explored.
3-Morpholinosydnonimine (SIN-1), a peroxynitrite genera-
tor described as inducing phosphorylation of protein tyrosine 
residues in brain cells (29), has been used as a neuronal damage 
inductor. It is able to produce peroxynitrite (ONOO−) from 
nitrogen monoxide (NO) and superoxide anion ( )O2
⋅− . ONOO− 
is one of the most reactive species implicated in causing 
damage in several cellular functions (i.e., oxidation of DNA, 
lipids, and protein sulfhydryls or the nitration of DNA and 
tyrosine) (30). In the present study, SIN-1-induced nitrosative 
stress in a human neuroblastoma cell line (SH-SY5Y) was used 
as a model of neuroinflammation (29, 30) in order to study 
the protective effects of wine-derived human gut metabolites, 
mainly phenolic compounds (3,4-dihydroxyphenylacetic, 
3-(4-hydroxyphenyl)propionic, 3-hydroxyphenylacetic (3HPA), 
and 3-(3-hydroxyphenyl) propionic acid, salicylic acid, β-d-O-
glucuronide of salicylic acid) and aroma compounds (linalool 
and 1,8-cineole) on neuronal survival, as well as their ability 
to interact with MAPK pathways (ERK1/2, JNK, p38) and 
downstream signaling processes (STAT 1, caspase-3).
eXPeriMenTal
chemicals
3,4-Dihydroxyphenylacetic acid (3,4-DHPA) and 3-(3-hydroxy-
phenyl) propionic acid (3HPP) were purchased from Alfa 
Aesar (Ward Hill, MA, USA). 3-(4-hydroxyphenyl) propionic 
acid (4HPP) was obtained from Sigma-Aldrich (Saint Louis, 
MO, USA), and 3HPA was purchased from Merck (Darmstadt, 
Germany). Salicylic acid (2-hydroxybenzoic acid) and its β-d-
O-glucuronide were from NE Scientific (Natick, MA, USA). 
Linalool and 1,8-cineole were purchased in Sigma-Aldrich 
(Saint Louis, MO, USA). Stock solutions of these compounds 
were freshly prepared and filtered (0.22  μM) in sterile PBS 
(1,000  μM). 3-Morpholinosydnonimine (SIN-1) was acquired 
from Alexis Biochemicals, Enzo Life Sciences (Exeter, UK). Anti-
GADPH was obtained from New England Biolabs (Hitchin, UK). 
Primary rabbit polyclonal antibodies specific for MAPK signal-
ing including total SAPK/JNK and phospho-SAPK/JNK (Thr183/
Tyr185), total p38 and phospho-p38 (Thr180/Tyr182), total ERK1/2 
and phospho-ERK1/2 (Thr202/Tyr204), and for total STAT-1 and 
phospho-STAT-1 (Tyr701) were from New England Biolabs 
(Hitchin, UK). Horseradish peroxidase (HRP)-conjugated 
goat anti-rabbit secondary antibody was obtained from Sigma-
Aldrich (Saint Louis, MO, USA). ECL® reagent and Hybond 
nitrocellulose membrane were purchased from Amersham 
Biosciences (Amersham, UK). All tissue culture reagents were 
purchased from Lonza (Slough, UK) and Invitrogen (Paisley, 
UK). MTT reagent was obtained from Sigma-Aldrich (Saint 
Louis, MO, USA).
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cell culture
SH-SY5Y (ATCC® CRL2266™) human neuroblastoma cell line 
was purchased from the American Type Culture Collection. Cells 
were routinely grown in 75 cm2 flasks in a mixture of Dulbecco’s 
modified Eagle Medium and Ham’s F12 (1:1 v/v) (Lonza, Slough, 
UK) supplemented with 10% fetal bovine serum, antibiotics 
(100  IU/mL penicillin and 100  μg/mL streptomycin) and 1% 
non-essential aminoacids (37°C and 5% CO2). Twenty-four hours 
prior to the experiments, cells were detached from flasks with 
trypsin-EDTA solution (Sigma-Aldrich, Saint Louis, MO, USA) 
and seeded on the respective plates.
assessment of cell Viability
Neuronal cells (4.105 cells/mL) were seeded on 96-well plates 
24  h prior to the incubation with the phenolic acids and 
aroma compounds (0.1–10 μM). After 18 h, cells were washed 
twice with DPBS solution (Lonza, Slough, UK) and Thiazolyl 
Blue Tetrazolium Bromide reagent (MTT) (0.5  mg/mL, final 
concentration) (Sigma-Aldrich, Saint Louis, MO, USA) was 
added. Then, plates were returned to the incubator (37°C, 5% 
CO2) for 3 h. Supernatant was carefully removed and formazan 
crystals were dissolved with pure DMSO before absorbance was 
measured (570 nm) on a Multiskan multiplate reader (Thermo 
Fisher, Waltham, MA, USA). Control (no compound added) 
was considered as maximum of percentage of viability (100%), 
and the sample values were calculated as: % viability = (Abssample/
Abscontrol) × 100. Assays were performed in triplicate.
neuroprotective effect against  
sin-1-induced cell Death
3-morpholinosydnonimine (SIN-1), a peroxynitrite generator 
has been used as a neuronal damage inductor. For the assays, 
neuronal cells (4 × 105 cells/mL) were seeded on 96-well plates 
24 h prior to the incubation with the phenolic acids and aroma 
compounds (0.1–10 μM; 18 h). Then, neuroblastoma cells were 
exposed to freshly prepared 1 mM SIN-1 for 0–15 h (37°C, 5% 
CO2) and MTT reagent was added (0.5  mg/mL). Plates were 
returned to the incubator for 3 h, and assay was performed as 
described above.
For MEK (PD98059, Calbiochem), p38 (SB203580, 
Calbiochem), and ERK (FR180204, Sigma-Aldrich) inhibitors, 
the same procedure was applied with the exception that neuro-
blastoma cells were pretreated for 1 h with different concentra-
tions of inhibitor (0.5–50  μM) prior the exposition to freshly 
prepared SIN-1 (1 mM) during 0–15 h. Assays were carried out 
in triplicates.
Modulation of MaPK signaling Pathway
To determine the ability of the phenolic acids and aroma com-
pounds to modulate SIN-1-induced MAPK and STAT-1 phos-
phorylation, neuronal cells (106 cells/mL) were seeded on 6-well 
plates 24 h prior to incubation with the compounds (0.1–10 μM; 
18 h). After this time, cells were activated with SIN-1 (500 μM) for 
1–2 h. Then, neuronal cells were first washed with ice-cold PBS 
with 200 μM EGTA and 200 μM EDTA and lysed on ice using 
50 mM Tris, 0.1% Triton X-100, 150 mM NaCl, and 2 mM EGTA/
EDTA, containing Complete® Protease Inhibitor Cocktail tablets 
and PhosStop® Phosphatase Inhibitor Cocktail Tablets (Roche, 
Basel, Switzerland). Lysed cells were scraped, left on ice to solu-
bilize for 45 min, and total protein concentration was determined 
by BCA assay (Pierce Kit, Thermo Scientific, Rockford, IL, USA) 
to normalize protein level. Samples were frozen at −80°C until 
further immunoblotting analysis.
Western immunoblotting
Immunoblotting was performed as previously described (25). 
Samples (20  μg protein/lane) were run on 10% pre-cast SDS-
polyacrylamide gels (Bio-Rad, Hemel Hempstead, UK), and pro-
teins were transferred to nitrocellulose membranes (Hybond-ECL) 
(Amersham, Buckinghamshire, UK) by semi-dry electroblotting 
(0.8 mA/cm2). Blots were incubated overnight at 4°C, with the 
primary antibodies described above (all 1:1,000 dilution) in Tris–
Tween Buffered Saline (TTBS) containing 1% (w/v) skimmed 
milk powder antibody buffer, on a three-dimensional rocking 
table. Afterward, the blots were washed with TTBS, incubated 
with goat anti-rabbit IgG conjugated to HRP secondary antibody 
(1:1,000 dilution) for 45 min, washed with TTBS and then exposed 
to ECL-reagent® for 1.5 min and developed using ImageQuant™ 
LAS mini 4000 (GE Healthcare, Buckinghamshire, UK). Bands 
were analyzed using ImageQuant™ Software (GE Healthcare, 
Buckinghamshire, UK). Molecular weights of the bands were 
calculated from comparison with prestained molecular weight 
markers (MW 10–250  kDa) (BioRad, Hemel Hempstead, UK), 
which were run in parallel with the samples. The equal loading 
and efficient transfer of proteins was confirmed by using GADPH 
as internal control.
caspase-3 activity
Neuroblastoma cells (106 cells/mL) were seeded on 6-wells plates 
24 h prior the pretreatment with wine constituents (0.1–10 μM; 
18 h) or MAPK inhibitors (0.5–50 μM; 1 h) exposure to SIN-1 
(1  mM; 6  h). Culture was then washed twice with ice-cold 
PBS + EGTA + EDTA (200 μM), and the cells were lysed and 
collected as previously described. The activity of caspase-3-like 
proteases in the lysates was determined using the caspase-3 
colorimetric assay kit (Sigma, Poole, Dorset, UK) according 
to the manufacturer’s protocol, with the exception that 30  μL 
of cell lysate was used in assays. Absorbance data (405  nm) 
obtained using the caspase-3 inhibitors were subtracted from 
the absorbance obtained without caspase-3 inhibitor to correct 
for any non-specific hydrolysis. Vehicle controls and blanks were 
incorporated, and caspase-3 protein was used as a positive control 
of the assay. Assays were carried out in triplicates.
statistical analysis
Data were expressed as the mean ± SEM of three independent 
experiments. Statistical analysis was made using one-way analy-
sis of variance, followed by a post hoc Dunnett test of each time 
point to look for significant differences with respect to SIN-1 
condition (positive control). Significance level was set at p < 0.05. 
Statistics analysis was carried out using STATISTICA program 
for Windows, version 7.1 (StatSoft. Inc., 1984–2006).
FigUre 1 | neuroprotective effects of phenolic acids (a–F) and aroma compounds (g,h) against sin-1-induced damage in sh-sY5Y cells. Following 
pretreatment with wine compounds (0.1–10 μM) or media (control) for 18 h, cells were exposed to SIN-1 (1 mM) for 0–15 h, before assessment of viability (%) by 
MTT assay. Results are expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significantly different from 
SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.
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resUlTs
ability of Phenolic acids and aroma 
compounds to Protect neuroblastoma 
cells against sin-1-induced neurotoxicity
None of the selected compounds (0.1–10  μM) affected cell 
viability (%) (data not shown) in relation to the control (no 
added compound). Pretreatment with 10  μM 3,4-DHPA acid 
resulted in a significant increase in cell viability against SIN-
1-induced neuronal death (Figure  1A) when compared to the 
SIN-1 control group, regardless of the length of time of exposure 
to SIN-1 (4 h: p < 0.01; 6–15 h: p < 0.001). The lower concentra-
tions of 3,4-DHPA (<10 μM) were also effective, but only during 
reduced time exposures to SIN-1 (4  h: p <  0.001). Significant 
protective actions were also observed for 4HPP (10 μM; p < 0.01) 
(Figure  1B); 3HPP (10 μM, p <  0.05) (Figure  1C) and 3HPA 
(0.1–10 μM, p < 0.05) (Figure 1D), when SIN-1-induced toxicity 
was less prolonged (4–6 h). A similar trend was observed for both 
salicylic acid (Figure 1E) and its glucuronide (Figure 1F), which 
were shown to be protective against SIN-1 after 4  h exposure, 
but innefective for longer periods (6–15 h). All concentrations 
of glucuronide of salicylic acid tested were effective at maintain-
ing cell viability after 4 h of SIN-1 exposure (0.1 μM, p < 0.001; 
1–10 μM, p < 0.05) (Figure 1F), while for salicylic acid, only 1 μM 
concentration resulted in a significant increase in cell survival 
(p < 0.05) (Figure 1E).
Aroma compounds 1,8-cineole and linalool (Figures 1G,H) 
showed a neuroprotective effect at specific concentrations and 
specific times of exposure. 1,8-Cineole was able to increase cell 
viability after 9 h SIN-1 incubation (p < 0.01) (Figure 1G), while 
linalool was only effective after shorter periods of SIN-1 exposure 
(4 h; p < 0.05) (Figure 1H).
effect of Phenolic acids and aroma 
compounds on sin-1-induced p38 
Phosphorylation
Exposure of SH-SY5Y cells to SIN-1 (1 h in all the cases, except for 
salicylic acid and its glucuronide that was exposed for 2 h; 500 μM) 
FigUre 2 | inhibition of p38 phosphorylation in sin-1 activated sh-sY5Y cells. Cells were treated with SIN-1 (500 μM) for 1 h in all the cases except for 
salicylic acid and its glucuronidie that was exposed for 2 h, after being pretreated with wine compounds (0.1–10 μM) for 18 h. Crude homogenates (20 μg) were 
immunoblotted with antibodies that detect endogenous levels of p38 only when phosphorylated. Data obtained from immunoblot experiments with p38 were 
analyzed using Image Quant LAS 4000 mini software, and each column represents the mean ± SEM of three independent experiments. (a) Phosphorylation status 
of p38 after incubation with phenolic acids [DHPA, 4HPP, 3HPP, and 3-hydroxyphenylacetic (3HPA)]. 1: control; 2: SIN-1; 3–5: DHPA (0.1, 1, and 10 μM, 
respectively); 6–8: 4HPP (0.1, 1, and 10 μM, respectively); 9–11: 3HPP (0.1, 1, and 10 μM, respectively); 12–14: 3HPA (0.1, 1, and 10 μM, respectively). * Indicates 
values significant different (p < 0.05) from SIN-1 group as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test.  
(B) Phosphorylation status of p38 after incubation with salicylic acid and its glucuronide. 15: control; 16: SIN-1; 17–19: salicylic acid (0.1, 1, and 10 μM, 
respectively); 20–22: β-d-O-glucuronide (0.1, 1, and 10 μM, respectively). * Indicates values significant different (p < 0.06) from SIN-1 group as analyzed by one-way 
ANOVA followed by Dunnett comparison test. (c) Phosphorylation status of p38 after incubation with aroma compounds. 23: control; 24: SIN-1; 25–27 linalool (0.1, 
1, and 10 μM, respectively); 28–30 1,8-cineole (0.1, 1, and 10 μM, respectively). *p < 0.05 indicates values significant different (except p < 0.06 in the case of 
control) from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.
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resulted in a significant increase in the phosphorylation of p38 
when compared to the control (p < 0.05) (Figure 2). Treatment 
of the cells with wine-derived compounds (0.1–10 μM for 18 h) 
prior to exposure to SIN-1 only resulted in a significant inhibition 
of p38 phosphorylation status for 4HPP (p <  0.01) and 3HPA 
(p < 0.05) at the lower concentration (0.1 μM) (Figures 2A,B). 
The aroma compound 1,8-cineole also exerted a significant inhi-
bition of p38 at all concentrations tested (0.1–10 μM; p < 0.05) 
(Figure 2C).
effect of Phenolic acids and aroma 
compounds on sin-1-induced erK1/2 
Phosphorylation
Exposure of neuroblastoma cells to SIN-1 (1 h; 500 μM) leads to a 
significant increase of ERK1/2 phosphorylation when compared 
to the control (p <  0.05) (Figures  3 and 4). Pretreatment with 
wine-derived phenolic acids 3,4-DHPA, 4HPP, 3HPP, and 3HPA 
resulted in a significant decrease in ERK1/2 phosphorylation at all 
FigUre 4 | inhibition of erK1/2 phosphorylation in sin-1 activated sh-sY5Y cells. (a) Data obtained from immunoblot experiments with ERK1 were 
analyzed using Image Quant LAS 4000 mini software and each column represents the mean ± SEM of three independent experiments. *p < 0.05 indicates values 
significant different from SIN-1 group as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test. (B) Data obtained from 
immunoblot experiments with ERK2 were analyzed using Image Quant™ Software, and each column represents the mean ± SEM of three independent 
experiments. *p < 0.05 indicates values significant different from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test. (c) Western 
blot of the aroma compounds (linalool and 1,8-cineole) inhibition of ERK1/2 phosphorylation in SIN-1-activated neuronal cells. Cells were treated with SIN-1 
(500 μM) for 1 h after being pretreated with aroma compounds (0.1–10 μM) for 24 h. Crude homogenates (20 μg) were immunoblotted with antibodies that detect 
endogenous levels of ERK 1/2 only when phosphorylated. 1: control; 2: SIN-1; 3–5: linalool (0.1, 1, and 10 μM, respectively); 6–8: 1,8-cineole (0.1, 1, and 10 μM, 
respectively).
FigUre 3 | inhibition of erK1/2 phosphorylation in sin-1 activated sh-sY5Y cells. (a) Data obtained from immunoblot experiments with ERK1 were 
analyzed using Image Quant LAS 4000 mini software and each column represents the mean ± SEM of three independent experiments. *p < 0.05, **p < 0.01 
indicate values significant different from SIN-1 group as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test. (B) Data obtained 
from immunoblot experiments with ERK2 were analyzed using Image Quant™ Software, and each column represents the mean ± SEM of three independent 
experiments. *p < 0.05, **p < 0.01 indicate values significant different from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.  
(c) Western blot of the phenolic acids (DHPA, 4HPP, 3HPP, and 3-hydroxyphenylacetic (3HPA)) inhibition of ERK1/2 phosphorylation in SIN-1-activated neuronal 
cells. Cells were treated with SIN-1 (500 μM) for 1 h after being pretreated with phenolic acids (0.1–10 μM) for 24 h. Crude homogenates (20 μg) were 
immunoblotted with antibodies that detect endogenous levels of ERK 1/2 only when phosphorylated. 1: control; 2: SIN-1; 3–5: DHPA (0.1, 1, and 10 μM, 
respectively); 6–8: 4HPP (0.1, 1, and 10 μM, respectively); 9–11: 3HPP (0.1, 1, and 10 μM, respectively); 12–14: 3HPA (0.1, 1, and 10 μM, respectively).
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concentrations tested (p < 0.01), reaching similar levels as control 
(Figure 3). Similarly, the aroma compounds, linalool and 1,8-cin-
eole exerted a significant reduction in ERK1/2 activation (at all 
concentrations tested) (p < 0.05) in relation to the SIN-1 group 
(Figure 4). Regarding salicylic acid and its glucuronide, no modu-
latory effect over ERK1/2 phosphorylation was observed (data not 
shown). We observed no modulation of JNK and STAT-1 by SIN-1 
or any of the wine-derived compounds tested (data not shown).
FigUre 5 | relative activity of caspase-3 protein (%) in sh-sY5Y cells after sin-1-induced damage. Cells were pretreated with phenolic (a–F) and aroma 
compounds (g,h) or media (control) for 18 h before SIN-1 incubation. After 6 h exposure, cells were washed, scraped, and lysed. Lysates were analyzed by 
Caspase-3 colorimetric assay. Data are indicated as% of caspase-3 activity, considering SIN-1 group the maximum activity for this protein (100%). Results are 
expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significant different from SIN-1 group as analyzed 
by one-way ANOVA followed by Dunnett comparison test.
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effect of Phenolic acids and aroma 
compounds in caspase-3 activation 
Following sin-1-induced neuronal 
Damage
Treatment of SH-SY5Y cells with SIN-1 (6 h; 1 mM) resulted in a 
significant increase of caspase-3 activation in relation to control 
(p < 0.001) (Figure 5). When administered at 10 μM, phenolic 
acid 3HPP reduced significantly caspase-3 activation (p < 0.01) 
in relation to SIN-1 control (Figure 5C). The aroma compound 
linalool (1, 10 μM) also showed a significant reduction (p < 0.01 
and p < 0.001, respectively) in the activation of caspase-3 in rela-
tion to SIN-1-treated cells (Figure 5H).
effect of MaPK signaling inhibitors in cell 
Viability and caspase-3 activation after 
sin-1-induced neuronal Damage
Inhibition of ERK1/2 (FR180204) and upstream MEK1 (PD98059) 
significantly increased cell viability (p < 0.05), with the highest 
concentration tested being the most effective (50  μM) against 
(4–15 h) SIN-1-induced toxicity (Figure 6A). Inhibition of p38 
(SB203580) resulted in an increased of cell viability (at 4 h SIN-1 
incubation) only when administered at the highest concentration 
(50 μM) (p < 0.05) (Figure 6A).
Furthermore, inhibition of p38, MEK, and ERK1/2 resulted 
in an overall significant reduction of caspase-3 activation, which 
confirms that SIN-1-induced MAPK signaling is linked to the 
activation of caspase-3 protein (Figure 6B). Specifically, p38 inhi-
bition consistently decreased caspase-3 protein activation, with 
all the concentrations tested being equally effective (p < 0.001). 
For MEK and ERK1/2 not all concentrations resulted in a signifi-
cant reduction in caspase-3 activity. In particular, MEK inhibitor 
concentrations were effective in reducing caspase-3 activity only 
when administered at 0.5 and 5 μM (p <  0.05), while ERK1/2 
inhibitor doses were effective at 0.5 and 50 μM (p < 0.01).
DiscUssiOn
Specific wine-derived phenolic compounds were selected for the 
present study given their bioavailability in urine and feces after 
moderate and regular wine consumption in humans (31, 32). In 
support of our model, Gasperotti and colleagues (16) recently 
FigUre 6 | (a) Neuroprotective effects of p38 inhibitor (SB203580), MEK inhibitor (PD98059), and ERK inhibitor (FR180204) against SIN-1-induced damage in 
SH-SY5Y cells. Following pretreatment with inhibitors for 1 h or media (control), cells were exposed to SIN-1 (1 mM) for 0–15 h, before assessment of viability by 
MTT assay. Results are expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significantly different from 
SIN-1 group (zero) as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test. (B) Relative activity of Caspase-3 protein (%) in 
SH-SY5Y cells after SIN-1-induced damage. Cells were pretreated with inhibitors for 1 h before SIN-1 incubation. After 6 h exposure, cells were washed, scraped, 
and lysed. Lysates were analyzed by Caspase-3 colorimetric assay. Data are indicated as% of caspase-3 activity, considering SIN-1 group the maximum activity for 
this protein (100%). Results are expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significant 
different from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.
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reported that phenolic acids 3HPA, 3,4-DHPA, and HPP were 
present in the brain of rats following intake of 23 polyphenol 
microbial metabolites. Similarly, Wang et al. (17) observed that 
3-hidroxybenzoic acid and 3HPP were also accumulated in 
rodent brains at μM concentrations after orally administration of 
grape seed polyphenols extract. Altogether, this strongly suggests 
that microbial-derived phenolic acids can cross the BBB in vivo, 
and therefore, they have the potential to act centrally. The stress 
induced by SIN-1 led to a significant and time-dependent cell 
death in SH-SY5Y cell line. In a similar manner, SIN-1 treat-
ment resulted in a significant phosphorylation of ERK1/2 and 
p38 MAPK proteins, as well as downstream caspase-3 protein 
activation. In agreement with our results, other assays in the 
same cellular model have demonstrated that peroxynitrite is able 
to induce neuronal damage via ERK1/2 and p38 modulation, as 
well as to induce caspase-3 protein activation (29, 30, 33, 34), 
which validates our model.
In this study, 3,4-DHPA showed a strong protective effect 
against SIN-1 induced-cell death, especially at 10  μM. This is 
in agreement with previous studies where 3,4-DHPA, at similar 
doses (20  μM), completely blocked the effect of peroxynitrite 
on tyrosine hydroxylase, an enzyme involved in Parkinson’s 
disease pathology (35). Furthermore, recent evidences showed 
a preventive action of this phenolic metabolite in dysfunctional 
pancreatic-β-cells (36), even at not physiologically relevant 
concentrations (up to 250 μM), as well as on mice liver after intra-
gastrically administration of 3,4-DHPA (10, 20, or 50 mg/kg) for 
3 days (37). Additionally, in the meanline of the redaction process 
of this paper, new evidence was reported showing the ability of a 
panel of phenolic metabolites, noting 3,4-DHPA among them, to 
prevent neuronal death after oxidative (H2O2) induced injury in 
the SH-SY5Y cellular model at a similar range of concentrations 
(1–10 μM) (38). β-d-O-Glucuronide of salicylic acid also showed a 
significant neuroprotective effect in the present study, unlike what 
was observed for its aglycone as González-Sarrias et al. (38) also 
reported. In disagreement with the weaker ability to access cells 
of glucuronide forms (39), some studies proposed the possibility 
of β-glucuronidases cleaving the glucuronide form and releasing 
the free aglycone (40). Further significant reductions of cell death 
were also seen for 4HPP, 3HPP, 3HPA, linalool, and 1,8-cineole, 
particularly at shorter incubation times. In similar conditions, 
previous research showed a neuroprotective effect of champagne 
wine polyphenols, including gallic acid, caffeic acid, and tyrosol 
(0.1 and 10 μM) on primary cortical neurons (41) after SIN-1-
induced damage and after S-cysteinyl-dopamine toxin exposition 
(42), as well as (−)-epicatechin oligomers have been described to 
neutralize peroxynitrite damage (0–20 μM) (43).
When pro-inflammatory signals are triggered in the central 
nervous system following nitrosative stress, MAPK kinases, such 
as ERK1/2, JNK, and p38 (24), become phosphorylated, leading 
to the activation of transcription factors, such as STAT-1 (1), and 
favoring the activation of proteins related to cellular damage, 
inflammation, and apoptosis, such as caspase-3. p38 protein has 
been related to neuronal stress and the control of cell death and 
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survival (44), while the role of ERK1/2 on this balance is con-
troversial. This protein has been usually linked to a pro-survival 
function (45); however, several studies demonstrated a role of 
ERK1/2 on oxidative stress-induced apoptosis (33, 46–48). This is 
in agreement with our results, where an increase of pERK1/2 was 
observed after SIN-1 treatment. Additionally, the use of ERK1/2 
specific inhibitor resulted in an increase of cell viability after SIN-1 
induced-stress. All the phenylacetic and phenylpropionic acids 
(3,4-DHPA, 4HPP, 3HPP, and 3HPA) and aroma compounds 
(linalool and 1,8-cineole) tested showed a modulatory effect on 
SIN-1 induced-phosphorylation of ERK1/2. On the other hand, 
no modulation of ERK1/2 was observed for salicylic acid and its 
glucuronide, which might indicate that they act through alterna-
tive pathways, such as NF-κB, described to be modulated by a 
salicylic acid analog (49). In addition, 4HPP and 3HPA (0.1 μM), 
as well as 1,8-cineole (0.1–10 μM) also significantly modulated 
p38 phosphorylation. Several lines of research have demonstrated 
a modulation of MAPK by a wide range of polyphenols (24) 
especially, flavonoids (1, 24, 50). For instance, naringenin was 
able to modulate p38 phosphorylation (0.01–0.3 μM) in a neu-
roinflammation primary mixed glial cells model (25). Similarly, 
(−) epicatechin is also able to interact with JNK and ERK1/2 
at physiologically relevant concentrations to protect neurons 
against oxidative stress-induced death (51). However, these stud-
ies have mainly focused on the effects of aglycones (24), not in 
physiologically relevant microbial metabolites that are found in 
the circulation following polyphenols-rich food intake (38, 52). 
As exception, the protocatechuic acid (3,4-dihydroxybenzoic 
acid), was shown to modulate inflammation via modulation of 
BDNF, resulting in amelioration of cognitive deficits, as well as to 
attenuate amyloid deposits in aged AβPP/PS1 double transgenic 
mice (100  mg/kg/day during 4  weeks) (53). Regarding aroma 
compounds, both 1,8-cineole and linalool, have been previously 
described to modulate in  vitro stress-induced signaling path-
ways, such as NF-kB (21, 22). Concurrently, and in agreement 
with our results, 1,8-cineole was described to interact with p38 
MAPK protein in an asthma model of bronchial epithelial cells 
(54). These observations were in  vivo corroborated, with the 
exposure to 1,8-cineole resulting in better cognitive performance 
in a pilot clinical human study (n = 20) (20). Additionally, oral 
administration of linalool (25 mg/kg for 3 months) to Alzheimer’s 
triple transgenic mice showed a beneficial effect on behavioral 
FigUre 7 | Proposed scheme of the mitogen-activated protein kinase (MaPK) signaling cascade after a stress-induced phosphorylation in neurons 
and its implication in the balance of cell apoptosis and survival signals. Phosphorylation of MAPK (p38 or ERK) leads to the activation of several proteins, 
including caspase-3, and therefore resulting in a modification of the balance between apoptotic and pro-survival signals in neurons. The activation of MAPK could 
be modified by the action of wine constituents, including phenolic acids and aroma compounds.
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